molnlycke health care limited
molnlycke health care limited Company Information
Company Number
03493645
Website
www.molnlycke.co.ukRegistered Address
unity house medlock street, oldham, OL1 3HS
Industry
Manufacture of basic pharmaceutical products
Telephone
01908355200
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
mhc uk ltd 100%
molnlycke health care limited Estimated Valuation
Pomanda estimates the enterprise value of MOLNLYCKE HEALTH CARE LIMITED at £226.5m based on a Turnover of £110.3m and 2.05x industry multiple (adjusted for size and gross margin).
molnlycke health care limited Estimated Valuation
Pomanda estimates the enterprise value of MOLNLYCKE HEALTH CARE LIMITED at £49.8m based on an EBITDA of £5.4m and a 9.19x industry multiple (adjusted for size and gross margin).
molnlycke health care limited Estimated Valuation
Pomanda estimates the enterprise value of MOLNLYCKE HEALTH CARE LIMITED at £10.7m based on Net Assets of £19.3m and 0.56x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Molnlycke Health Care Limited Overview
Molnlycke Health Care Limited is a live company located in oldham, OL1 3HS with a Companies House number of 03493645. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in January 1998, it's largest shareholder is mhc uk ltd with a 100% stake. Molnlycke Health Care Limited is a mature, mega sized company, Pomanda has estimated its turnover at £110.3m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Molnlycke Health Care Limited Health Check
Pomanda's financial health check has awarded Molnlycke Health Care Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs
3 Strong
4 Regular
4 Weak
Size
annual sales of £110.3m, make it larger than the average company (£30.7m)
£110.3m - Molnlycke Health Care Limited
£30.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 15%, show it is growing at a faster rate (3.8%)
15% - Molnlycke Health Care Limited
3.8% - Industry AVG
Production
with a gross margin of 17.8%, this company has a higher cost of product (38.6%)
17.8% - Molnlycke Health Care Limited
38.6% - Industry AVG
Profitability
an operating margin of 4.8% make it less profitable than the average company (6.5%)
4.8% - Molnlycke Health Care Limited
6.5% - Industry AVG
Employees
with 156 employees, this is similar to the industry average (135)
156 - Molnlycke Health Care Limited
135 - Industry AVG
Pay Structure
on an average salary of £101.4k, the company has a higher pay structure (£58.3k)
£101.4k - Molnlycke Health Care Limited
£58.3k - Industry AVG
Efficiency
resulting in sales per employee of £706.9k, this is more efficient (£277.9k)
£706.9k - Molnlycke Health Care Limited
£277.9k - Industry AVG
Debtor Days
it gets paid by customers after 64 days, this is near the average (56 days)
64 days - Molnlycke Health Care Limited
56 days - Industry AVG
Creditor Days
its suppliers are paid after 6 days, this is quicker than average (40 days)
6 days - Molnlycke Health Care Limited
40 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Molnlycke Health Care Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 10 weeks, this is average cash available to meet short term requirements (12 weeks)
10 weeks - Molnlycke Health Care Limited
12 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 48.8%, this is a similar level of debt than the average (46.2%)
48.8% - Molnlycke Health Care Limited
46.2% - Industry AVG
MOLNLYCKE HEALTH CARE LIMITED financials
Molnlycke Health Care Limited's latest turnover from December 2022 is £110.3 million and the company has net assets of £19.3 million. According to their latest financial statements, Molnlycke Health Care Limited has 156 employees and maintains cash reserves of £3.8 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 110,273,000 | 118,876,000 | 159,715,000 | 72,706,000 | 70,189,000 | 74,337,000 | 79,545,000 | 81,178,000 | 84,257,000 | 80,969,000 | 81,951,000 | 83,693,000 | 85,194,000 | 86,695,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 90,636,000 | 107,173,000 | 145,655,000 | 57,966,000 | 55,940,000 | 61,321,000 | 64,591,000 | 66,212,000 | 69,199,000 | 64,583,000 | 66,879,000 | 67,051,000 | 69,381,000 | 70,714,000 |
| Gross Profit | 19,637,000 | 11,703,000 | 14,060,000 | 14,740,000 | 14,249,000 | 13,016,000 | 14,954,000 | 14,966,000 | 15,058,000 | 16,386,000 | 15,072,000 | 16,642,000 | 15,813,000 | 15,981,000 |
| Admin Expenses | 14,334,000 | 8,929,000 | 9,324,000 | 10,092,000 | 10,253,000 | 10,314,000 | 10,564,000 | 15,311,000 | 12,013,000 | 13,633,000 | 13,400,000 | 13,869,000 | 13,720,000 | 12,434,000 |
| Operating Profit | 5,303,000 | 2,774,000 | 4,736,000 | 4,648,000 | 3,996,000 | 2,702,000 | 4,390,000 | -345,000 | 3,045,000 | 2,753,000 | 1,672,000 | 2,773,000 | 2,093,000 | 3,547,000 |
| Interest Payable | 71,000 | 113,000 | 48,000 | 77,000 | 168,000 | 95,000 | 81,000 | 0 | 0 | 0 | 0 | 0 | 0 | 4,000 |
| Interest Receivable | 18,000 | 55,000 | 0 | 0 | 0 | 0 | 0 | 1,000 | 5,000 | 2,000 | 41,000 | 74,000 | 38,000 | 32,000 |
| Pre-Tax Profit | 5,250,000 | 2,716,000 | 4,688,000 | 4,571,000 | 3,828,000 | 2,607,000 | 4,309,000 | -344,000 | 3,050,000 | 2,755,000 | 1,713,000 | 2,847,000 | 2,131,000 | 3,575,000 |
| Tax | -1,007,000 | -552,000 | -922,000 | -908,000 | -790,000 | -532,000 | -892,000 | -726,000 | -698,000 | -634,000 | -505,000 | -840,000 | -697,000 | -1,141,000 |
| Profit After Tax | 4,243,000 | 2,164,000 | 3,766,000 | 3,663,000 | 3,038,000 | 2,075,000 | 3,417,000 | -1,070,000 | 2,352,000 | 2,121,000 | 1,208,000 | 2,007,000 | 1,434,000 | 2,434,000 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 2,300,000 | 0 | 1,800,000 | 2,666,000 | 1,208,000 | 2,007,000 | 1,434,000 | 7,598,000 | 0 |
| Retained Profit | 4,243,000 | 2,164,000 | 3,766,000 | 3,663,000 | 3,038,000 | -225,000 | 3,417,000 | -2,870,000 | -314,000 | 913,000 | -799,000 | 573,000 | -6,164,000 | 2,434,000 |
| Employee Costs | 15,819,000 | 13,185,000 | 12,976,000 | 12,363,000 | 11,015,000 | 11,424,000 | 12,046,000 | 10,835,000 | 12,544,000 | 11,982,000 | 13,614,000 | 13,733,000 | 14,167,000 | 13,576,000 |
| Number Of Employees | 156 | 119 | 143 | 159 | 165 | 168 | 184 | 191 | 212 | 219 | 129 | 206 | 268 | 271 |
| EBITDA* | 5,424,000 | 2,903,000 | 4,906,000 | 4,798,000 | 4,169,000 | 2,948,000 | 4,621,000 | -140,000 | 3,223,000 | 2,940,000 | 1,873,000 | 2,958,000 | 2,262,000 | 3,708,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 661,000 | 634,000 | 678,000 | 752,000 | 814,000 | 898,000 | 978,000 | 810,000 | 767,000 | 79,000 | 144,000 | 158,000 | 113,000 | 117,000 |
| Intangible Assets | 53,000 | 80,000 | 136,000 | 223,000 | 192,000 | 213,000 | 329,000 | 445,000 | 561,000 | 677,000 | 793,000 | 908,000 | 1,024,000 | 1,140,000 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 714,000 | 714,000 | 814,000 | 975,000 | 1,006,000 | 1,111,000 | 1,307,000 | 1,255,000 | 1,328,000 | 756,000 | 937,000 | 1,066,000 | 1,137,000 | 1,257,000 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 7,000 | 20,000 | 19,000 | 13,000 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 19,503,000 | 10,162,000 | 22,094,000 | 7,355,000 | 8,395,000 | 8,113,000 | 8,902,000 | 8,815,000 | 10,243,000 | 9,937,000 | 7,467,000 | 10,505,000 | 8,491,000 | 8,982,000 |
| Group Debtors | 11,074,000 | 16,097,000 | 100,292,000 | 14,493,000 | 6,683,000 | 2,092,000 | 1,941,000 | 4,813,000 | 11,355,000 | 3,153,000 | 5,695,000 | 30,697,000 | 22,556,000 | 17,579,000 |
| Misc Debtors | 2,519,000 | 4,671,000 | 2,025,000 | 568,000 | 4,590,000 | 5,323,000 | 312,000 | 1,027,000 | 774,000 | 696,000 | 674,000 | 2,629,000 | 2,273,000 | 516,000 |
| Cash | 3,771,000 | 5,322,000 | 6,932,000 | 3,770,000 | 4,740,000 | 6,603,000 | 4,692,000 | 3,736,000 | 4,990,000 | 6,587,000 | 5,775,000 | 5,254,000 | 5,295,000 | 6,208,000 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 36,867,000 | 36,252,000 | 131,343,000 | 26,186,000 | 24,408,000 | 22,138,000 | 15,867,000 | 18,410,000 | 27,375,000 | 20,373,000 | 19,611,000 | 49,085,000 | 38,615,000 | 33,285,000 |
| total assets | 37,581,000 | 36,966,000 | 132,157,000 | 27,161,000 | 25,414,000 | 23,249,000 | 17,174,000 | 19,665,000 | 28,703,000 | 21,129,000 | 20,548,000 | 50,151,000 | 39,752,000 | 34,542,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 1,714,000 | 308,000 | 806,000 | 681,000 | 819,000 | 613,000 | 611,000 | 826,000 | 655,000 | 725,000 | 682,000 | 1,178,000 | 1,039,000 | 1,157,000 |
| Group/Directors Accounts | 8,684,000 | 15,596,000 | 83,115,000 | 9,080,000 | 12,353,000 | 13,464,000 | 6,607,000 | 12,159,000 | 18,130,000 | 9,931,000 | 10,419,000 | 39,700,000 | 30,632,000 | 18,354,000 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 7,836,000 | 5,942,000 | 35,305,000 | 8,241,000 | 6,734,000 | 6,690,000 | 7,217,000 | 7,113,000 | 7,692,000 | 7,392,000 | 7,989,000 | 7,016,000 | 6,397,000 | 7,183,000 |
| total current liabilities | 18,234,000 | 21,846,000 | 119,226,000 | 18,002,000 | 19,906,000 | 20,767,000 | 14,435,000 | 20,098,000 | 26,477,000 | 18,048,000 | 19,090,000 | 47,894,000 | 38,068,000 | 26,694,000 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 94,000 | 110,000 | 85,000 | 79,000 | 91,000 | 103,000 | 135,000 | 380,000 | 169,000 | 710,000 | 0 | 0 | 0 | 0 |
| total long term liabilities | 94,000 | 110,000 | 85,000 | 79,000 | 91,000 | 103,000 | 135,000 | 380,000 | 169,000 | 710,000 | 0 | 0 | 0 | 0 |
| total liabilities | 18,328,000 | 21,956,000 | 119,311,000 | 18,081,000 | 19,997,000 | 20,870,000 | 14,570,000 | 20,478,000 | 26,646,000 | 18,758,000 | 19,090,000 | 47,894,000 | 38,068,000 | 26,694,000 |
| net assets | 19,253,000 | 15,010,000 | 12,846,000 | 9,080,000 | 5,417,000 | 2,379,000 | 2,604,000 | -813,000 | 2,057,000 | 2,371,000 | 1,458,000 | 2,257,000 | 1,684,000 | 7,848,000 |
| total shareholders funds | 19,253,000 | 15,010,000 | 12,846,000 | 9,080,000 | 5,417,000 | 2,379,000 | 2,604,000 | -813,000 | 2,057,000 | 2,371,000 | 1,458,000 | 2,257,000 | 1,684,000 | 7,848,000 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 5,303,000 | 2,774,000 | 4,736,000 | 4,648,000 | 3,996,000 | 2,702,000 | 4,390,000 | -345,000 | 3,045,000 | 2,753,000 | 1,672,000 | 2,773,000 | 2,093,000 | 3,547,000 |
| Depreciation | 94,000 | 73,000 | 83,000 | 91,000 | 109,000 | 130,000 | 115,000 | 89,000 | 62,000 | 71,000 | 86,000 | 69,000 | 53,000 | 46,000 |
| Amortisation | 27,000 | 56,000 | 87,000 | 59,000 | 64,000 | 116,000 | 116,000 | 116,000 | 116,000 | 116,000 | 115,000 | 116,000 | 116,000 | 115,000 |
| Tax | -1,007,000 | -552,000 | -922,000 | -908,000 | -790,000 | -532,000 | -892,000 | -726,000 | -698,000 | -634,000 | -505,000 | -840,000 | -697,000 | -1,141,000 |
| Stock | 0 | 0 | 0 | 0 | -7,000 | -13,000 | 1,000 | 6,000 | 13,000 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 2,166,000 | -93,481,000 | 101,995,000 | 2,748,000 | 4,140,000 | 4,373,000 | -3,500,000 | -7,717,000 | 8,586,000 | -50,000 | -29,995,000 | 10,511,000 | 6,243,000 | 27,077,000 |
| Creditors | 1,406,000 | -498,000 | 125,000 | -138,000 | 206,000 | 2,000 | -215,000 | 171,000 | -70,000 | 43,000 | -496,000 | 139,000 | -118,000 | 1,157,000 |
| Accruals and Deferred Income | 1,894,000 | -29,363,000 | 27,064,000 | 1,507,000 | 44,000 | -527,000 | 104,000 | -579,000 | 300,000 | -597,000 | 973,000 | 619,000 | -786,000 | 7,183,000 |
| Deferred Taxes & Provisions | -16,000 | 25,000 | 6,000 | -12,000 | -12,000 | -32,000 | -245,000 | 211,000 | -541,000 | 710,000 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 5,535,000 | 65,996,000 | -70,816,000 | 2,499,000 | -516,000 | -2,501,000 | 6,872,000 | 6,648,000 | -6,385,000 | 2,512,000 | 31,840,000 | -7,635,000 | -5,582,000 | -16,170,000 |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -6,912,000 | -67,519,000 | 74,035,000 | -3,273,000 | -1,111,000 | 6,857,000 | -5,552,000 | -5,971,000 | 8,199,000 | -488,000 | -29,281,000 | 9,068,000 | 12,278,000 | 18,354,000 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | -53,000 | -58,000 | -48,000 | -77,000 | -168,000 | -95,000 | -81,000 | 1,000 | 5,000 | 2,000 | 41,000 | 74,000 | 38,000 | 28,000 |
| cash flow from financing | -6,965,000 | -67,577,000 | 73,987,000 | -3,350,000 | -1,279,000 | 6,762,000 | -5,633,000 | -5,970,000 | 8,204,000 | -486,000 | -29,240,000 | 9,142,000 | 12,316,000 | 23,796,000 |
| cash and cash equivalents | ||||||||||||||
| cash | -1,551,000 | -1,610,000 | 3,162,000 | -970,000 | -1,863,000 | 1,911,000 | 956,000 | -1,254,000 | -1,597,000 | 812,000 | 521,000 | -41,000 | -913,000 | 6,208,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -1,551,000 | -1,610,000 | 3,162,000 | -970,000 | -1,863,000 | 1,911,000 | 956,000 | -1,254,000 | -1,597,000 | 812,000 | 521,000 | -41,000 | -913,000 | 6,208,000 |
molnlycke health care limited Credit Report and Business Information
Molnlycke Health Care Limited Competitor Analysis
Perform a competitor analysis for molnlycke health care limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mega companies, companies in OL1 area or any other competitors across 12 key performance metrics.
molnlycke health care limited Ownership
MOLNLYCKE HEALTH CARE LIMITED group structure
Molnlycke Health Care Limited has no subsidiary companies.
Ultimate parent company
INVESTOR AB
#0022706
2 parents
MOLNLYCKE HEALTH CARE LIMITED
03493645
molnlycke health care limited directors
Molnlycke Health Care Limited currently has 3 directors. The longest serving directors include Mr Adrian Muellar (Jun 2020) and Mr Adrian Muellar (Jun 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Adrian Muellar | England | 47 years | Jun 2020 | - | Director |
| Mr Adrian Muellar | England | 47 years | Jun 2020 | - | Director |
| Mr James Hockley | England | 46 years | Apr 2023 | - | Director |
P&L
December 2022turnover
110.3m
-7%
operating profit
5.3m
+91%
gross margin
17.9%
+80.89%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
19.3m
+0.28%
total assets
37.6m
+0.02%
cash
3.8m
-0.29%
net assets
Total assets minus all liabilities
Similar Companies
molnlycke health care limited company details
company number
03493645
Type
Private limited with Share Capital
industry
21100 - Manufacture of basic pharmaceutical products
incorporation date
January 1998
age
26
incorporated
UK
accounts
Full Accounts
ultimate parent company
previous names
molku uk limited (February 1998)
last accounts submitted
December 2022
address
unity house medlock street, oldham, OL1 3HS
accountant
-
auditor
DELOITTE LLP
molnlycke health care limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to molnlycke health care limited. Currently there are 0 open charges and 2 have been satisfied in the past.
molnlycke health care limited Companies House Filings - See Documents
| date | description | view/download |
|---|
